Form 4 for BCDA BioCardia, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001437749-25-037474 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-10 | 2025-12-08 | BCDA | McClung David | CFO | F - Tax | $1.37 | +29.3K | 76.9K | +62% | +$40.2K |
| D | 2025-12-10 | 2025-12-08 | BCDA | McClung David | CFO | A - Grant | $1.37 | +58.3K | 106.2K | +122% | +$79.8K |
| D | 2025-12-10 | 2025-12-08 | BCDA | McClung David | CFO | A - Grant | $0.00 | +27.0K | 46.3K | +140% | $0 |
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | F | A | 29,339 | $1.37 | 76,887 | D | — | — | (F2) The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement of the RSUs vested on December 8, 2025 and does not represent a sale by the Reporting Person. |
| 2 | Common | Common Stock | 2025-12-08 | A | A | 58,276 | $1.37 | 106,226 | D | — | — | (F1) The reported securities represent restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock awarded as compensation in lieu of cash. 100% of the RSUs vested on December 8, 2025. |
| 3 | Derivative | Stock Option (right to buy) | 2025-12-08 | A | A | 27,000 | $0.00 | 46,340 | D | $1.37 · — to 2035-12-08 | 20,000 Common stock | (F3) The option vests and becomes exercisable as to 1/48th of the shares on January 8, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date. |